Gene Thomas – Biography

Gene Thomas (61) has over 30 years of executive level management experience working with technology

based companies, healthcare institutions ranging from startups to a Fortune 500 public company.

Gene worked at Memorial Hospital and Physicians Clinics at Gulfport for 12 years. Gene started at
Memorial as Interim Director of IS. That resulting in becoming Vice President and Chief Information
Officer and a member of administration. Responsibilities included all technology assets at the health
system, software applications, electronic medical record, finance, revenue cycle and biomedical
equipment. Gene led the initiative to select and install a multi-million dollar (5yr TCO) project for a new
system wide Cerner electronic medical record, Health Catalyst EDW and Oracle based ERP set of
applications. Gene was the initial Executive Sponsor when Memorial entered its first MSSP ACO. Gene
remains active in the ACO as an Executive Consultant to Memorial Hospital and Physician’s clinics in
Gulfport Mississippi. His current part time work at Memorial is in Value Base Care and Population Health

Gene is the founder of Thriving Populace. A pending not for profit focused on population health
and per member per year cost reductions. Thriving Populace has a multifaceted plan to improve
patient (consumer) compliance with a physician’s prescribed plan of care and known lifestyles that
collectively prevent and or control chronic conditions and reduced overall healthcare expense.

Gene is Chairman of the Board of Milimatch – A cognitive linguistics approach to
better hiring, retention and life cycle of staff. Currently Milimatch if focused on home health and healthcare

Gene is a Board member and shareholder of Innosurance, a technology company that patented and
trademarked the Driver Safety Rating (DSR) algorithm. The intellectual property was purchased by Allstate
and used as their (DSR™) under the brand name of Drivewise®.

Mr. Thomas has experience in emerging technologies as well as startup and development technology
companies. Since 1984, Mr. Thomas has worked in management and executive level positions where he
provided strategy, product development, sales and marketing for CompuAdd, Micron Electronics, Avreo,
and Bio-tech companies and healthcare providers.

Gene began his career with Polaroid Corporation in sales and marketing in the electronic imaging group. He
gained significant experience in hyper-growth companies with seven years at CompuAdd, where he held
senior level positions in sales and marketing. Gene participated in developing and managing CompuAdd,
to become one of the largest direct marketing technology companies in the late 80’s and early 90’s. His
performance eventually led to his selection to play a key role in expansion where he held the position of
Managing Director of Sales and Marketing in the United Kingdom.

After CompuAdd, Gene was recruited as Vice President of sales and marketing for Micron Electronics
where he had responsibility for all sales, marketing, customer service, technical support and product
management. During his years at Micron, Gene was instrumental in the development of the strategy that
launched Micron into the competitive high-end server and technology market. He navigated the changing
environment as Micron grew to a publicly traded multi-billion-dollar company with over 4,000
employees. Gene was an officer of Micron Electronics, which eventually became the 9th largest supplier
of personal computers, notebooks and servers in the country.

After Micron Electronics, he became a consultant working for the Dean of LSU School of Medicine. He
provided expertise in engaging technology companies to participate in LSU’s Advanced Learning Center.
After working with LSU, he was recruited to be CEO and Chairman of Avreo Inc, a radiology information
systems company. Gene successfully raised millions of dollars needed to initiate and launch Avreo’s
concepts and products in the radiology information system market. In 2002, Gene successfully negotiated
a majority sale of the company to one of the largest investors and a key distributor.

He went on to become President of Advanced Bio/Chem, a proteomics research and diagnostic
company. He negotiated intellectual property rights and technology transfer agreements with MD
Anderson / University of Texas Health Science Center.

Gene has been involved as an investor, board member or consultant with start-up companies as well as
established operating companies. He has experience in entity structuring, strategic planning and
professional fundraising at the executive and board level. With a strong business and healthcare
background, Gene focuses on prevention and control of chronic conditions.

Additionally, Gene works independently on the perceived shortage of organ donations.